Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

GBD 2021 Suicide Collaborators. Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health 2025; 10: ...

Born in Taixing near Shanghai, China, Jian Zhou's inspiration to become a doctor came from his maternal grandfather, who had ...

A healthy 57-year-old female patient presented to Chang Gung Memorial Hospital (Kaohsiung, Taiwan) in February, 2025, with a 6-month history of a progressively enlarging wound on her left forearm. She ...

As early as 2005, Gritz and colleagues drew attention to clinical trialists missing the potential impact of tobacco use on cancer treatment outcomes, as smoking status was rarely recorded in cancer ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Each year, World Hepatitis Day reminds the global health community of its collective commitment to eliminating viral hepatitis as a public health threat by 2030. Yet, as momentum grows toward ...

Pope Francis was viewed as relatively progressive. His successor, the first American pope, is now in a unique position to influence global health. Sima Barmania reports.

In the phase 3 PEARL studies, Marcus Maurer and colleagues1 investigated the efficacy of ligelizumab for the treatment of moderate-to-severe H1-antihistamine refractory chronic spontaneous urticaria ...

Often overlooked as a dimension of the health effects of war, the impacts of conflict on the environment are gaining increasing attention. Rebecca Sers reports.

In 2022, an estimated 11·7 million people were affected by chronic hepatitis C virus (HCV) infection in the WHO Eastern Mediterranean Region (EMR), accounting for 23% of the global burden.1 This ...

Study offers an important advancement in understanding symptom dynamics during the menopause transition, particularly by challenging the dominance of menstrual-based staging. Although criteria such as ...